CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Open-market sale Chief Executive Officer sold 110,000 shares at $25.00 ($2,750,000)
- 4 Open-market sale Chief Executive Officer sold 200,000 shares at $25.00 ($5,000,000)
- 4 Open-market sale Chief Executive Officer sold 200,000 shares at $25.00 ($5,000,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4/A Grant or award Chief Development Officer acquired 5,939 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 7,967 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 109,625 shares at an average $25.31 ($2,774,755)
- 4 Open-market sale Chief Executive Officer sold 200,000 shares at an average $25.96 ($5,191,827)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 22,950 shares at an average $27.18 ($623,767)
- 4 Open-market sale Director sold 66,241 shares at an average $28.20 ($1,868,150)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 20 of 32 · 631 filings